Company Behind Defective CPAP Machines Must Make Changes Before U.S. Production Resumes
By Robin Foster HealthDay Reporter
WEDNESDAY, April 10, 2024 -- Phillips Respironics, the company responsible for the recall of millions of defective sleep apnea machines since 2021, must overhaul its production of the machines before it can resume making them in the United States, federal officials announced Tuesday.
Under a settlement reached with the company, Phillips must revamp its manufacturing and quality control systems and hire independent experts to vet the changes. Phillips must also continue to replace, repair or provide refunds to all U.S. customers who got defective devices, the court order stated.
The action helps resolve one of the biggest medical device recalls in history, which has dragged on for nearly three years and involved 15 million devices worldwide, the U.S. Food and Drug Administration said.
“The finalization of this decree is a significant milestone. Throughout this recall, we have provided patients with important health information by issuing numerous safety communications and have taken actions rarely used by the agency to help protect those impacted by this recall,” Dr. Jeff Shuren, director of the FDA's Center for Devices and Radiological Health, said in an agency news release. “Today’s action is a culmination of those efforts and includes novel provisions aimed at helping ensure that patients receive the relief they have long deserved.”
Most of the devices that have been recalled are continuous positive airway pressure (CPAP) machines. These devices force air through a mask to keep a patient's mouth and nasal passageways open during sleep. Left untreated, sleep apnea can increase the risk of heart attack.
With the recalled machines, foam inside the machine can break down over time, leading users to inhale tiny particles and fumes while they sleep.
Jeffrey Reed, of Marysville, Ohio, experienced sinus infections and two bouts of pneumonia during the seven years he used a Philips CPAP machine.
“I worry about my long-term health,” Reed told the Associated Press. “I used this machine for years and no matter what money I might get out of this, what’s going to happen?”
Reed received a newer Philips device after returning his old machine, but he prefers a competitor’s device.
“I don’t trust the company,” Reed said. “I don’t want to use it.”
Reed is one of more than 750 people who have filed personal injury lawsuits against the company over the devices. Those cases have been consolidated in a federal court in Pennsylvania, the AP reported.
Sources
- U.S. Food and Drug Administration, news release, April 10, 2024
- Associated Press
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
Sleep Apnea Linked With Late-Life Epilepsy
THURSDAY, May 2, 2024 -- Add one more damaging consequence of sleep apnea to the list: New research suggests it's related to late-life epilepsy. Late-onset epilepsy is defined as...
Weight-loss Drug Zepbound Eases Sleep Apnea in Company Trials
WEDNESDAY, April 17, 2024 -- Zepbound, one of the wildly popular weight-loss drugs that millions of Americans now take, eased sleep apnea in obese adults in two company trials...
Americans Short on Sleep, Stressed Out About It: Poll
MONDAY, April 15, 2024 -- While more than half of Americans say they would feel better with more sleep, only 42% say they are getting as much shut-eye as they need, a new poll...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
